BACKGROUND: We evaluated the effectiveness of eradication of methicillin-resistant Staphylococcus aureus (MRSA) carriage in the Netherlands after the introduction of a guideline in 2006. The guideline distinguishes complicated (defined as the presence of MRSA infection, skin lesions, foreign-body material, mupirocin resistance and/or exclusive extranasal carriage) and uncomplicated carriage (not meeting criteria for complicated carriage). Mupirocin nasal ointment and chlorhexidine soap solution are recommended for uncomplicated carriers and the same treatment in combination with two oral antibiotics for complicated carriage. METHODS: A prospective cohort study was performed in 18 Dutch centres from 1 October 2006 until 1 October 2008. RESULTS: Six hundred and thirteen MRSA carriers underwent one or more decolonization treatments during the study period, mostly after hospital discharge. Decolonization was achieved in 367 (60%) patients with one eradication attempt and ultimately 493 (80%) patients were decolonized, with a median time until decolonization of 10 days (interquartile range 7-43 days). Three hundred and twenty-seven (62%) carriers were treated according to the guideline, which was associated with an absolute increase in treatment success of 20% [from 45% (91/203) to 65% (214/327)]. CONCLUSIONS: Sixty percent of MRSA carriers were successfully decolonized after the first eradication attempt and 62% were treated according to the guideline, which was associated with an increased treatment success.
BACKGROUND: We evaluated the effectiveness of eradication of methicillin-resistant Staphylococcus aureus (MRSA) carriage in the Netherlands after the introduction of a guideline in 2006. The guideline distinguishes complicated (defined as the presence of MRSA infection, skin lesions, foreign-body material, mupirocin resistance and/or exclusive extranasal carriage) and uncomplicated carriage (not meeting criteria for complicated carriage). Mupirocin nasal ointment and chlorhexidine soap solution are recommended for uncomplicated carriers and the same treatment in combination with two oral antibiotics for complicated carriage. METHODS: A prospective cohort study was performed in 18 Dutch centres from 1 October 2006 until 1 October 2008. RESULTS: Six hundred and thirteen MRSA carriers underwent one or more decolonization treatments during the study period, mostly after hospital discharge. Decolonization was achieved in 367 (60%) patients with one eradication attempt and ultimately 493 (80%) patients were decolonized, with a median time until decolonization of 10 days (interquartile range 7-43 days). Three hundred and twenty-seven (62%) carriers were treated according to the guideline, which was associated with an absolute increase in treatment success of 20% [from 45% (91/203) to 65% (214/327)]. CONCLUSIONS: Sixty percent of MRSA carriers were successfully decolonized after the first eradication attempt and 62% were treated according to the guideline, which was associated with an increased treatment success.
Authors: Valerie C Cluzet; Jeffrey S Gerber; Irving Nachamkin; Joshua P Metlay; Theoklis E Zaoutis; Meghan F Davis; Kathleen G Julian; David Royer; Darren R Linkin; Susan E Coffin; David J Margolis; Judd E Hollander; Rakesh D Mistry; Laurence J Gavin; Pam Tolomeo; Jacqueleen A Wise; Mary K Wheeler; Warren B Bilker; Xiaoyan Han; Baofeng Hu; Neil O Fishman; Ebbing Lautenbach Journal: Clin Infect Dis Date: 2015-02-03 Impact factor: 9.079
Authors: Jens Hachenberg; Christian Eichler; Ellen Acis; Maximilian Mattes Auer-Schmidt; Mathias Warm; Wolfram Malter; Fabinshy Thangarajah Journal: In Vivo Date: 2021 Jan-Feb Impact factor: 2.155
Authors: A Pan; E Bombana; G Tura; C Curti; S Lorenzotti; P Mondello; A Patroni; E Tacconelli; V Rigobello; L Signorini; M Vizio; A Goglio Journal: Infection Date: 2013-04-01 Impact factor: 3.553
Authors: G Pichler; C Pux; R Babeluk; B Hermann; E Stoiser; A De Campo; A Grisold; I Zollner-Schwetz; R Krause; W Schippinger Journal: Eur J Clin Microbiol Infect Dis Date: 2017-08-28 Impact factor: 3.267
Authors: Karen L Kotloff; Debbie-Ann T Shirley; C Buddy Creech; Sharon E Frey; Christopher J Harrison; Mary Staat; Evan J Anderson; Susan Dulkerian; Isaac P Thomsen; Mohamad Al-Hosni; Barbara A Pahud; David I Bernstein; Jumi Yi; Joshua E Petrikin; Beth Haberman; Kathy Stephens; Ina Stephens; Randolph E Oler; Tom M Conrad Journal: Pediatrics Date: 2019-01 Impact factor: 7.124
Authors: Jason E Farley; Laura E Starbird; Jill Anderson; Nancy A Perrin; Kelly Lowensen; Tracy Ross; Karen C Carroll Journal: Am J Infect Control Date: 2017-07-03 Impact factor: 2.918
Authors: O Baud; S Giron; C Aumeran; D Mouly; G Bardon; M Besson; J Delmas; B Coignard; A Tristan; F Vandenesch; G Illes; O Lesens Journal: Eur J Clin Microbiol Infect Dis Date: 2014-05-11 Impact factor: 3.267